Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olli Kallioniemi

Showing results (111-120 of 184) with videos related to

Pageof 19
Sort By:
The Journal of Pathology. Clinical Research|May 6, 2021
High tumor cell platelet-derived growth factor receptor beta expression is associated with shorter survival in malignant pleural epithelioid mesotheliomaHely Ollila, Juuso Paajanen, Henrik Wolff, et al.
Cancer Research|February 24, 2011
Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cellsPäivi Östling, Suvi-Katri Leivonen, Anna Aakula, et al.
International Journal of Cancer|April 2, 2014
A novel transcript, VNN1-AB, as a biomarker for colorectal cancerMarthe Løvf, Torfinn Nome, Jarle Bruun, et al.
Cell Death & Disease|September 29, 2020
Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemnessHanna Karvonen, Mariliina Arjama, Laura Kaleva, et al.
European Urology|February 8, 2011
MicroRNA in prostate, bladder, and kidney cancer: a systematic reviewJames W F Catto, Antonio Alcaraz, Anders S Bjartell, et al.
The American Journal of Pathology|February 2, 2011
Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancerPaula Vainio, Santosh Gupta, Kirsi Ketola, et al.
Molecular Oncology|December 10, 2021
E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical modelsJarle Bruun, Peter W Eide, Christian Holst Bergsland, et al.
Leukemia|July 18, 2020
KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemiaDisha Malani, Bhagwan Yadav, Ashwini Kumar, et al.
Plos One|March 3, 2011
GTI: a novel algorithm for identifying outlier gene expression profiles from integrated microarray datasetsJohn Patrick Mpindi, Henri Sara, Saija Haapa-Paananen, et al.
Molecular Oncology|December 21, 2012
The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cellsKristine Kleivi Sahlberg, Vesa Hongisto, Henrik Edgren, et al.
Pageof 19

Showing results (111-120 of 184) with videos related to

Sort By:
Pageof 19
The Journal of Pathology. Clinical Research|May 6, 2021
High tumor cell platelet-derived growth factor receptor beta expression is associated with shorter survival in malignant pleural epithelioid mesotheliomaHely Ollila, Juuso Paajanen, Henrik Wolff, et al.
Cancer Research|February 24, 2011
Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cellsPäivi Östling, Suvi-Katri Leivonen, Anna Aakula, et al.
International Journal of Cancer|April 2, 2014
A novel transcript, VNN1-AB, as a biomarker for colorectal cancerMarthe Løvf, Torfinn Nome, Jarle Bruun, et al.
Cell Death & Disease|September 29, 2020
Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemnessHanna Karvonen, Mariliina Arjama, Laura Kaleva, et al.
European Urology|February 8, 2011
MicroRNA in prostate, bladder, and kidney cancer: a systematic reviewJames W F Catto, Antonio Alcaraz, Anders S Bjartell, et al.
The American Journal of Pathology|February 2, 2011
Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancerPaula Vainio, Santosh Gupta, Kirsi Ketola, et al.
Molecular Oncology|December 10, 2021
E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical modelsJarle Bruun, Peter W Eide, Christian Holst Bergsland, et al.
Leukemia|July 18, 2020
KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemiaDisha Malani, Bhagwan Yadav, Ashwini Kumar, et al.
Plos One|March 3, 2011
GTI: a novel algorithm for identifying outlier gene expression profiles from integrated microarray datasetsJohn Patrick Mpindi, Henri Sara, Saija Haapa-Paananen, et al.
Molecular Oncology|December 21, 2012
The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cellsKristine Kleivi Sahlberg, Vesa Hongisto, Henrik Edgren, et al.
Pageof 19